Cargando…
Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs
The discovery of novel anti-leishmanial compounds remains essential as current treatments have known limitations and there are insufficient novel compounds in development. We have investigated three complex and physiologically relevant in vitro assays, including: (i) a media perfusion based cell cul...
Autores principales: | O’Keeffe, Alec, Hale, Christine, Cotton, James A., Yardley, Vanessa, Gupta, Kapish, Ananthanarayanan, Abhishek, Murdan, Sudaxshina, Croft, Simon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356592/ https://www.ncbi.nlm.nih.gov/pubmed/32492796 http://dx.doi.org/10.3390/microorganisms8060831 |
Ejemplares similares
-
Development of an in vitro media perfusion model of Leishmania major macrophage infection
por: O’Keeffe, Alec, et al.
Publicado: (2019) -
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
por: Riezk, Alaa, et al.
Publicado: (2020) -
Activity of Chitosan and Its Derivatives against Leishmania major and Leishmania mexicana
In Vitro
por: Riezk, Alaa, et al.
Publicado: (2020) -
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2017) -
Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2018)